🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
BSX
NYSE
🇺🇸 US
Boston Scientific
Healthcare
58Score
DipBuster Score™
$45.51
+$1.26 (+2.85%)
Live price · Source: Yahoo
52-Week Position
$42.20
5% of range
$109.50
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
BetaN/A
52W High$109.50
52W Low$42.20
DipBuster Brief
Key signals at a glance
Zone: Strong Buy
Bullish
Near 52-Week Low — Wide Margin of Safety
At 5% of its annual range the stock is near its floor, offering value investors a cushion before fundamentals need to re-rate.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position5% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta—
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Boston Scientific (BSX), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-07-01 | Monson Jonathan | SELL | 2,087 |
| 2026-07-01 | Monson Jonathan | SELL | 1,010 |
| 2026-07-01 | Monson Jonathan | BUY | 2,087 |
| 2026-05-28 | Mahoney Michael F | SELL | 386,755 |
| 2026-05-20 | Pegus Cheryl | BUY | 1,770 |
| 2026-05-20 | Habiger David C | BUY | 2,250 |
| 2026-05-20 | Ludwig Edward J | BUY | 3,580 |
| 2026-05-19 | Habiger David C | BUY | 2,200 |
| 2026-05-07 | Morano Susan E | BUY | 1,281 |
| 2026-05-07 | Morano Susan E | BUY | 3,800 |
Valuation
P/E RatioN/A
Market CapN/A
BetaN/A
Dividend/yrNone
52W High$109.50
52W Low$42.20
52-Week Range
$42.20Now$109.50
5% through annual range
From 52W High−58.4%
From 52W Low+7.8%
📖 Plain English Summary
Boston Scientific is at 5% of its 52-week range.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for BSX
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — BSX
Heuristic · balance sheet, insider filings, price data, academic research
Boston Scientific — DipBuster Score 58/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Boston Scientific free
Add BSX to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
38/25
Momentum & Volume
15/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
48
/100 · WATCH
dip depth
24/25
oversold rsi
0/25
mean reversion
0/15
insider zone
25/25
capitulation
0/10
Insiders' avg buy price: $56.53 — marked 🟡 on the chart above.
Technical signal only. Not financial advice.
Quick Take
🟢
Dip Signal
DipBuster Score: 58/100
📈
Strong recent momentum — price and volume trending in the right direction.